Category: US MSOs
-
Cannabis memory lane: Who’s sticking it out, who’s dead and dying
I was feeling every ounce of my chest cold, the thing everyone apparently has, the one that’s going around, the one that’s not covid but who could tell. I was also standing on a stage at the Richmond Chamber of Commerce awards gala, blinking at stage lights and peaking over the shoulders of some very…
-
Stately’s long road to public finally finds an onramp with Gold Flora/TCPO (GRAM.NEO)
Good things happen in sunny Costa Mesa, California and, today, one of those good things happened for a certain group of cannabis investors. Longtime readers may recall Trent Kitsch, who founded Doja Cannabis (which would be consumed by Canopy Growth Corp for $400m), had bounced to his next venture not long after that deal closed…
-
Canntab (PILL.C) yeets another patent for hard-pressed, long release cannabis pills
I’ve made no secret of the fact that the Canadian cannabis market frequently annoys the hell out of me. What I want is for it to be a mature space that more and more adults are making use of, and that is free to innovate, free to be excellent, free to market itself properly, and…
-
Heritage Cannabis (CANN.C) up hard on Alberta sales news
No cannabis companies splits investors squarely down the middle like Heritage Cannabis (CANN.C). Despite ongoing good news and deals with larger players, a sizable section of the legacy cannabis investing community has just never been able to get on board with the Canadian weedco – until this week. Our Joseph Morton blew the trumpet on…
-
iAnthus (IAN.C) shareholders all but wiped out by Gotham Green Partners in recapitalization deal
For a large part of its early days, one of the main selling points of US multi state cannabis store operator iAnthus (IAN.C) was that it was seemingly run by adults. Unlike their colleagues at MedMen (MMEN.C), which revealed itself as a self-dealing executive wealth generator from day one, iAnthus painted a picture of experience,…
-
Canopy Growth Corp (WEED.T) to detonate another $800m in assets in bid to find balance sheet harmony
There’s no doubt a lot of people invest in a sector by just plopping their dough behind whichever company is the biggest, or the one they’ve heard of most, without actually looking at the fundamentals of that company. This is as much a cemented belief for me as the belief that songs that get played…
-
iAnthus (IAN.C) defaults on debenture payments – but is that a weakness or a tactic?
Long time readers know, a year or two back, we wrote a lot about a US multi-state operator (MSO) in the cannabis dispensary space, iAnthus (IAN.C). We liked the company as it accelerated its dispensary acquisition program but stopped coverage in early 2019, with the shareprice in the $5 range, as it began to overpay…
-
2020 Gravitas Securities Growth Conference lines up seriously interesting deals, even in weed
Respect where it’s due, I haven’t been to an investor conference in a long time where I came away interested in most of what I saw, let alone *everything* I saw, but this year’s Gravitas Securities Growth Conference lineup absolutely hit it out of the park. The GSGC isn’t the biggest show around, but they…
-
1933 Industries (TGIF.C) blows up, jumps 35% preceding California harvest announcement
You’ve gotta love it when a plan comes together: 1933 Industries (TGIF.C), which has been banging the same ‘we’re grownups, we’re doing it right, hang tight’ drum for several years now, dropped news this February 14 that will make any Valentine’s heart swell with joy. “Following the completion of a combined 20,000-square-foot expanded cultivation, extraction,…
-
MedMen (MMEN.C) lay offs reveal an even deeper sickness within
So the braintrusts over at MedMen (MMEN.C) have devised a new and novel way to staunch their company’s steady and consistent bleeding: they’re going to lay enough people off that they reduce their overhead to a sustainable rate. Given that the company lost $277 Million in 2019, it’s not unexpected. Sometimes costs need to be…